Press Releases Archives - Page 85 of 103 - Lupin

BSE 2328.10 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2328.10 NSE 2324.50

US FDA clears Lupin’s Mandideep Facility

December 30, 2011

Lupin receives Tentative Approval for Generic Cymbalta® Delayed-release Capsules

December 9, 2011

Lupin receives FDA Approval for Generic SOLODYN® Tablets

December 2, 2011

Lupin Acquires I’rom Pharmaceuticals through its Japanese Subsidiary

November 17, 2011

Robust Growth, Record Profits Net Profit Up 24%, Q2 FY 2011-12

November 9, 2011

Lupin receives Final FDA Approval for Generic LoSeasonique® Tablets

October 28, 2011

Lupin receives FDA approval for Generic KEPPRA® Oral Solution 100 mg / ml

October 19, 2011

Lupin launches Authorized Generic of Femcon® Fe

October 11, 2011

Lupin Announces Launch of Generic KEPPRA XR® Tablets

September 14, 2011

Lupin Announces U.S. FDA Approval of its First Oral Contraceptive

September 11, 2011

1 2 … 84 85 86 … 102 103

Search

Hit enter to search or ESC to close